Tag: clinical presentations

Classys Global Customer Summit 2026: Insights from 500 Medical Professionals Across 20 Countries

Classys successfully hosted its Global Customer Summit 2026, showcasing innovative medical devices and attracting over 500 professionals globally.

Top News

FDA Adjusts Drug Review Fees: Higher for New Drugs, Lower for...

News1 - August 7, 2026

The FDA’s 2027 fee changes lower review costs for new drugs and biosimilars while raising fees for generics and medical devices, with the impact varying by company.

Plaza Accord Redux?: The Politics Behind Rumored U.S.–Japan–Korea FX Coordination Ahead...

January 26, 2026

North Korea Promotes ‘Socialist Paradise’ While Reinforcing Anti-U.S. Messaging

July 13, 2026

Samsung Display’s Legal Win Over BOE Strengthens OLED Dominance

March 21, 2025

JW Pharmaceutical Secures Phase 1 Approval for Novel Hair Loss Treatment...

April 7, 2026

Novo Nordisk vs Eli Lilly: Is Weight Loss Advertising Misleading?

July 22, 2026

Belvarafenib: The Promising New Targeted Cancer Drug for NRAS Mutant Melanoma

July 10, 2026

ezCaretech Expands AI Native HIS Strategy Through New Partnership With Huinno

May 14, 2026

- Our Sponsors Ad -

Essential Guide to the 2026 Biohealth Supply Chain Stability Project: What You Need to Know

Foldable iPhone Finally Coming in 2026 — What to Expect

COLLISION COURSE: Chinese Warship Chases French Frigate—Is Our Watch On North Korea BLIND?

Tag: clinical presentations

Classys Global Customer Summit 2026: Insights from 500 Medical Professionals Across 20 Countries

Top News

FDA Adjusts Drug Review Fees: Higher for New Drugs, Lower for...

Plaza Accord Redux?: The Politics Behind Rumored U.S.–Japan–Korea FX Coordination Ahead...

North Korea Promotes ‘Socialist Paradise’ While Reinforcing Anti-U.S. Messaging

Samsung Display’s Legal Win Over BOE Strengthens OLED Dominance

JW Pharmaceutical Secures Phase 1 Approval for Novel Hair Loss Treatment...

Novo Nordisk vs Eli Lilly: Is Weight Loss Advertising Misleading?

Belvarafenib: The Promising New Targeted Cancer Drug for NRAS Mutant Melanoma

ezCaretech Expands AI Native HIS Strategy Through New Partnership With Huinno

Follow us

Cars

Tech

future

health